SIR Publishes Practice Guidance for PAE

June 2, 2026—The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH).

SIR stated that this document provides evidence-based guidance for health care providers on the clinical evaluation of BPH patients, appropriate diagnostic and preprocedural imaging, and appropriate treatments tailored to the diagnosis.

The guidance was published online by Samdeep Mouli, MD, et al in Journal of Vascular and Interventional Radiology. The society noted that the document was developed by an SIR-appointed writing group of interventional radiologists and researchers specializing in PAE in collaboration with the SIR Guidelines and Statements Division.

According to the press release, this update to SIR’s 2019 Multisociety Consensus Position Statement on PAE incorporates new evidence supporting PAE as an effective alternative to conventional surgical treatments such as transurethral resection of the prostate.

It also reflects the procedure’s acceptance by the American Urologic Association as a viable treatment option for managing BPH-related lower urinary tract symptoms, noted SIR.

“PAE offers men a minimally invasive, effective treatment option for enlarged prostate that can significantly improve urinary symptoms while reducing the risks and recovery time associated with traditional surgery,” commented SIR President Saher S. Sabri, MD, in the society’s press release. “This guidance outlines a team-based approach to care that will help ensure patients have access to this durable, minimally invasive treatment.”